As 2015 drew to a close, stem cell medicine biotechnology start-up company Asymmetrex began an effort to educate the pharmaceutical and regenerative medicine industries on the value of counting adult tissue stem cells. The company is now intensifying this effort with a newly developed free webinar and two scheduled conference presentations to clinical trial developers and the rapidly growing gene-editing therapeutics community.
(PRWeb March 02, 2016)
Read the full story at http://www.prweb.com/releases/2016/03/prweb13241118.htm
For more information, please visit
http://www.prweb.com/releases/2016/03/prweb13241118.htm